Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ALIGN TECHNOLOGY INCALGN · Entity 3488 | Director | May 20, 2026 | May 22, 2026 |
| REVA Medical, Inc.RVA.AX · Entity 11998 | Director | June 29, 2018 | July 03, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ALIGN TECHNOLOGY INC
Report date May 20, 2026 · Filed May 22, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 27,454 |
Reported balance
After 2026-05-20 transaction · row 1
1 source rowRow 1 · 2026-05-20 · Exercise / conversion · Acquired 2,326 · Balance 27,454 |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2026-05-20 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-05-20 · Exercise / conversion · Disposed 2,326 · Balance 0 F1: 100% of the restricted stock units ("RSUs") granted on May 21, 2025 vested on May 20, 2026 and shares were delivered to the Reporting Person. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 2,448 |
Reported balance
After 2026-05-20 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-05-20 · Grant · Acquired 2,448 · Balance 2,448 F2: 100% of the RSUs granted on May 20, 2026 will become vested on the earlier of (i) May 20, 2027 or (ii) the date of the next annual meeting of stockholders. Shares will be delivered to the Reporting Person on such vesting date assuming the continued service of the Reporting Person on such vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: 100% of the restricted stock units ("RSUs") granted on May 21, 2025 vested on May 20, 2026 and shares were delivered to the Reporting Person.
F2: 100% of the RSUs granted on May 20, 2026 will become vested on the earlier of (i) May 20, 2027 or (ii) the date of the next annual meeting of stockholders. Shares will be delivered to the Reporting Person on such vesting date assuming the continued service of the Reporting Person on such vesting date.
REVA Medical, Inc.
Report date June 29, 2018 · Filed July 03, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 371,380.5 |
Reported balance
After 2018-06-29 transaction · row 1
1 source rowRow 1 · 2018-06-29 · Purchase · Acquired 19,631.5 · Balance 371,380.5 F1: Represents the purchase of 196,315 of the Issuer's CHESS Depositary Interests (CDIs) trading on the Australian Securities Exchange. F2: The purchase was executed in the form of CDIs, trading on the Australian Securities Exchange, and as such the purchase price has been converted to a USD equivalent, adjusting for the conversion ratio of 1 share of common stock per 10 CDIs, and the exchange rate on the date of the transaction. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the purchase of 196,315 of the Issuer's CHESS Depositary Interests (CDIs) trading on the Australian Securities Exchange.
F2: The purchase was executed in the form of CDIs, trading on the Australian Securities Exchange, and as such the purchase price has been converted to a USD equivalent, adjusting for the conversion ratio of 1 share of common stock per 10 CDIs, and the exchange rate on the date of the transaction.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Shockwave Medical, Inc.
Report date May 31, 2024 · Filed May 31, 2024
Section 16 reporting ended · disclosed 2024-05-31. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2024-05-31 transaction · row 1
1 source rowRow 1 · 2024-05-31 · Disposition to issuer · Disposed 5,281 · Balance 0 F1: This Form 4 reports the disposition of securities pursuant to the terms of the Agreement and Plan of Merger (the "Merger Agreement"), dated as of April 4, 2024, by and among the Issuer, Johnson & Johnson ("J&J"), and Sweep Merger Sub, Inc., a wholly owned subsidiary of J&J ("Merger Sub"), pursuant to which Merger Sub merged with and into the Issuer (the "Merger"), effective as of the effective time of the Merger (the "Effective Time"), with the Issuer surviving the Merger as a wholly owned subsidiary of J&J. As a result of the Merger, at the Effective Time, each outstanding share of common stock, par value $0.001 per share, of the Issuer ("Common Stock") outstanding immediately prior to the Effective Time (excluding Excluded Shares and any Dissenting Company Shares, each as defined in the Merger Agreement) was automatically converted into the right to receive $335.00 in cash (the "Merger Consideration"), F2: (Continued from Footnote 1) without interest and less any applicable withholding taxes. Additionally, pursuant to the Merger Agreement, at the Effective Time, each restricted stock unit ("RSU") outstanding immediately prior to the Effective Time, whether vested or unvested, was cancelled and converted into the right to receive a cash amount, without interest and less any applicable withholding taxes, equal to the product of (i) the aggregate number of shares of Common Stock underlying such RSU immediately prior to the Effective Time and (ii) the Merger Consideration. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $6.59 · Expires 2029-02-01 | Direct | 0 |
Reported balance
After 2024-05-31 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2024-05-31 · Disposition to issuer · Disposed 28,688 · Balance 0 F3: Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of Common Stock ("Company Option") that was outstanding and unexercised as of immediately prior to the Effective Time, whether vested or unvested, with a per share exercise price that was less than the Merger Consideration, was cancelled and converted into the right to receive a cash amount, without interest and less any applicable withholding taxes, equal to the product of (i) the aggregate number of shares of Common Stock underlying such Company Option immediately prior to the Effective Time, and (ii) the excess of (A) the Merger Consideration over (B) the per share exercise price of such Company Option. |
Filing footnotes · ownership attribution and instrument terms
F1: This Form 4 reports the disposition of securities pursuant to the terms of the Agreement and Plan of Merger (the "Merger Agreement"), dated as of April 4, 2024, by and among the Issuer, Johnson & Johnson ("J&J"), and Sweep Merger Sub, Inc., a wholly owned subsidiary of J&J ("Merger Sub"), pursuant to which Merger Sub merged with and into the Issuer (the "Merger"), effective as of the effective time of the Merger (the "Effective Time"), with the Issuer surviving the Merger as a wholly owned subsidiary of J&J. As a result of the Merger, at the Effective Time, each outstanding share of common stock, par value $0.001 per share, of the Issuer ("Common Stock") outstanding immediately prior to the Effective Time (excluding Excluded Shares and any Dissenting Company Shares, each as defined in the Merger Agreement) was automatically converted into the right to receive $335.00 in cash (the "Merger Consideration"),
F2: (Continued from Footnote 1) without interest and less any applicable withholding taxes. Additionally, pursuant to the Merger Agreement, at the Effective Time, each restricted stock unit ("RSU") outstanding immediately prior to the Effective Time, whether vested or unvested, was cancelled and converted into the right to receive a cash amount, without interest and less any applicable withholding taxes, equal to the product of (i) the aggregate number of shares of Common Stock underlying such RSU immediately prior to the Effective Time and (ii) the Merger Consideration.
F3: Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of Common Stock ("Company Option") that was outstanding and unexercised as of immediately prior to the Effective Time, whether vested or unvested, with a per share exercise price that was less than the Merger Consideration, was cancelled and converted into the right to receive a cash amount, without interest and less any applicable withholding taxes, equal to the product of (i) the aggregate number of shares of Common Stock underlying such Company Option immediately prior to the Effective Time, and (ii) the excess of (A) the Merger Consideration over (B) the per share exercise price of such Company Option.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 30, 2019 Filed Mar 25, 2020 22:37 UTC Amendment | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | SaleCommon Stock | 18,700 | $295.67 | $5,529,029.00 |
DisclosureSEC source: 0001209191-20-021173 · doc4a.xml · nonDerivative · entry 1 LARKIN C RAYMOND JR · CIK 0001034464 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,200 F1 · price: The Reporting Person contributed 18,700 shares to an exchange fund in exchange for shares of that exchange fund. The price reported in column 4 was the ALGN common stock closing price per share on June 20, 2019, the date of closing of the transaction. F2 · balance_after: This represents the number of shares held by reporting person has of the date of filing of this Form 4A. Read SEC document |
| May 15, 2019 Filed May 18, 2019 01:48 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | GrantRestricted Stock Unit · Derivative | 1,228 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001288257-19-000011 · primary_doc.xml · derivative · entry 4 LARKIN C RAYMOND JR · CIK 0001034464 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,228 Underlying: Common Stock · 1,228 shares Expires not disclosed F3 · derivative.exercise_price: 100% of the restricted stock unit will become vested on the earlier of (i) May 15, 2020 or (ii) the date of the 2020 annual meeting of stockholders. Shares will be delivered to reporting person on the vest date. F3 · derivative.exercise_date: 100% of the restricted stock unit will become vested on the earlier of (i) May 15, 2020 or (ii) the date of the 2020 annual meeting of stockholders. Shares will be delivered to reporting person on the vest date. F3 · derivative.expiration_date: 100% of the restricted stock unit will become vested on the earlier of (i) May 15, 2020 or (ii) the date of the 2020 annual meeting of stockholders. Shares will be delivered to reporting person on the vest date. Read SEC document |
| May 15, 2019 Filed May 18, 2019 01:48 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | Exercise / conversionRestricted Stock Unit · Derivative | 1,390 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001288257-19-000011 · primary_doc.xml · derivative · entry 3 LARKIN C RAYMOND JR · CIK 0001034464 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,390 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Represents par value of ALGN common stock F2 · derivative.exercise_date: 100% of the restricted stock unit granted on May 16, 2018 became vested on May 15, 2019 and shares were delivered to reporting person on that date. F2 · derivative.expiration_date: 100% of the restricted stock unit granted on May 16, 2018 became vested on May 15, 2019 and shares were delivered to reporting person on that date. Read SEC document |
| May 15, 2019 Filed May 18, 2019 01:48 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | Exercise / conversionCommon Stock | 1,390 | $0.00 | $0.00 |
DisclosureSEC source: 0001288257-19-000011 · primary_doc.xml · nonDerivative · entry 2 LARKIN C RAYMOND JR · CIK 0001034464 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,991 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 29, 2019 Filed May 18, 2019 01:48 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | GiftCommon Stock | 146 | $0.00 | $0.00 |
DisclosureSEC source: 0001288257-19-000011 · primary_doc.xml · nonDerivative · entry 1 LARKIN C RAYMOND JR · CIK 0001034464 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,601 Read SEC document |
| September 25, 2018 Filed Jan 28, 2019 23:49 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | GiftCommon Stock | 39 | $0.00 | $0.00 |
DisclosureSEC source: 0001215490-19-000006 · primary_doc.xml · nonDerivative · entry 2 LARKIN C RAYMOND JR · CIK 0001034464 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,827 Read SEC document |
| August 14, 2018 Filed Jan 28, 2019 23:49 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | GiftCommon Stock | 27,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001215490-19-000006 · primary_doc.xml · nonDerivative · entry 1 LARKIN C RAYMOND JR · CIK 0001034464 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,866 Read SEC document |
| June 29, 2018 Filed Jul 3, 2018 00:00 UTC | REVA Medical, Inc. RVA.AX · Entity 11998 | PurchaseCommon Stock | 19,631.5 | $1.53 | $30,036.20 |
DisclosureSEC source: 0001209191-18-040515 · doc4.xml · nonDerivative · entry 1 LARKIN C RAYMOND JR · CIK 0001034464 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 371,380.5 F1 · shares: Represents the purchase of 196,315 of the Issuer's CHESS Depositary Interests (CDIs) trading on the Australian Securities Exchange. F2 · price: The purchase was executed in the form of CDIs, trading on the Australian Securities Exchange, and as such the purchase price has been converted to a USD equivalent, adjusting for the conversion ratio of 1 share of common stock per 10 CDIs, and the exchange rate on the date of the transaction. Read SEC document |
| June 04, 2018 Filed Feb 16, 2019 00:38 UTC Amendment | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | GiftCommon Stock | 122 | $0.00 | $0.00 |
DisclosureSEC source: 0001288257-19-000003 · primary_doc.xml · nonDerivative · entry 7 LARKIN C RAYMOND JR · CIK 0001034464 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,747 Read SEC document |
| May 16, 2018 Filed May 18, 2018 20:56 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | Exercise / conversionRestricted Stock Unit · Derivative | 1,390 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001288257-18-000002 · primary_doc.xml · derivative · entry 3 LARKIN C RAYMOND JR · CIK 0001034464 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,390 Underlying: Common Stock · 1,390 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Represents par value of ALGN Common Stock F3 · derivative.exercise_date: 100% of the restricted stock unit granted on May 16, 2018 will become vested on the earlier of (i) May 16, 2019 or (ii) the date of the 2019 annual meeting of stockholders. Shares will be delivered to reporting person on the vest date. F3 · derivative.expiration_date: 100% of the restricted stock unit granted on May 16, 2018 will become vested on the earlier of (i) May 16, 2019 or (ii) the date of the 2019 annual meeting of stockholders. Shares will be delivered to reporting person on the vest date. Read SEC document |
| May 16, 2018 Filed May 18, 2018 20:56 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | Exercise / conversionRestricted Stock Unit · Derivative | 4,344 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001288257-18-000002 · primary_doc.xml · derivative · entry 2 LARKIN C RAYMOND JR · CIK 0001034464 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,344 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Represents par value of ALGN Common Stock F2 · derivative.exercise_date: 100% of the restricted stock unit granted on May 17, 2017 became vested on May 16, 2018 and shares were delivered to reporting person on that date. F2 · derivative.expiration_date: 100% of the restricted stock unit granted on May 17, 2017 became vested on May 16, 2018 and shares were delivered to reporting person on that date. Read SEC document |
| May 16, 2018 Filed May 18, 2018 20:56 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | Exercise / conversionCommon Stock | 4,344 | $0.00 | $0.00 |
DisclosureSEC source: 0001288257-18-000002 · primary_doc.xml · nonDerivative · entry 1 LARKIN C RAYMOND JR · CIK 0001034464 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,266 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 16, 2018 Filed May 19, 2018 01:05 UTC | REVA Medical, Inc. RVA.AX · Entity 11998 | GrantStock Option (right to buy) · Derivative | 21,095 | $0.00 Strike: $1.96 | $0.00 |
DisclosureSEC source: 0001209191-18-031615 · doc4.xml · derivative · entry 2 LARKIN C RAYMOND JR · CIK 0001034464 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,095 Underlying: Common Stock · 21,095 shares Expires 2028-05-16 F2 · derivative.exercise_date: The option vests and becomes exercisable on May 16, 2019. Read SEC document |
| May 16, 2018 Filed May 19, 2018 01:05 UTC | REVA Medical, Inc. RVA.AX · Entity 11998 | GrantStock Option (right to buy) · Derivative | 40,000 | $0.00 Strike: $1.96 | $0.00 |
DisclosureSEC source: 0001209191-18-031615 · doc4.xml · derivative · entry 1 LARKIN C RAYMOND JR · CIK 0001034464 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2028-05-16 F1 · derivative.exercise_date: The option vests and becomes exercisable in three (3) equal annual installments beginning on May 16, 2019. Read SEC document |
| May 07, 2018 Filed May 8, 2018 21:59 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | Exercise / conversionRight to Buy (Common Stock) · Derivative | 15,000 | $0.00 Strike: $7.81 | $0.00 |
DisclosureSEC source: 0001234778-18-000001 · primary_doc.xml · derivative · entry 3 LARKIN C RAYMOND JR · CIK 0001034464 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires 2019-02-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 07, 2018 Filed May 8, 2018 21:59 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | SaleCommon Stock | 15,000 | $264.45 | $3,966,750.00 |
DisclosureSEC source: 0001234778-18-000001 · primary_doc.xml · nonDerivative · entry 2 LARKIN C RAYMOND JR · CIK 0001034464 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,922 F1 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $263.61 to $265.19, inclusive. The reporting person undertakes to provide Align Technology, Inc., any security holder of Align Technology, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 07, 2018 Filed May 8, 2018 21:59 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | Exercise / conversionCommon Stock | 15,000 | $7.81 | $117,150.00 |
DisclosureSEC source: 0001234778-18-000001 · primary_doc.xml · nonDerivative · entry 1 LARKIN C RAYMOND JR · CIK 0001034464 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,922 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 01, 2018 Filed Feb 16, 2019 00:38 UTC Amendment | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | GiftCommon Stock | 139 | $0.00 | $0.00 |
DisclosureSEC source: 0001288257-19-000003 · primary_doc.xml · nonDerivative · entry 6 LARKIN C RAYMOND JR · CIK 0001034464 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,869 Read SEC document |
| February 01, 2018 Filed Feb 16, 2019 00:38 UTC Amendment | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | GiftCommon Stock | 38 | $0.00 | $0.00 |
DisclosureSEC source: 0001288257-19-000003 · primary_doc.xml · nonDerivative · entry 5 LARKIN C RAYMOND JR · CIK 0001034464 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,008 Read SEC document |
| December 18, 2017 Filed Jan 25, 2018 00:17 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | GiftCommon Stock | 279 | $0.00 | $0.00 |
DisclosureSEC source: 0001593575-18-000002 · primary_doc.xml · nonDerivative · entry 1 LARKIN C RAYMOND JR · CIK 0001034464 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,922 Read SEC document |
| October 31, 2017 Filed Nov 1, 2017 23:29 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | Exercise / conversionRight to Buy (Common Stock) · Derivative | 15,000 | $0.00 Strike: $2.08 | $0.00 |
DisclosureSEC source: 0001234778-17-000007 · primary_doc.xml · derivative · entry 8 LARKIN C RAYMOND JR · CIK 0001034464 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires 2018-02-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 31, 2017 Filed Nov 1, 2017 23:29 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | SaleCommon Stock | 15,000 | $238.82 | $3,582,300.00 |
DisclosureSEC source: 0001234778-17-000007 · primary_doc.xml · nonDerivative · entry 7 LARKIN C RAYMOND JR · CIK 0001034464 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,201 F1 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $237.70 to $239.40, inclusive. The reporting person undertakes to provide Align Technology, Inc., any security holder of Align Technology, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| October 31, 2017 Filed Nov 1, 2017 23:29 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | Exercise / conversionCommon Stock | 15,000 | $20.79 | $311,850.00 |
DisclosureSEC source: 0001234778-17-000007 · primary_doc.xml · nonDerivative · entry 6 LARKIN C RAYMOND JR · CIK 0001034464 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,201 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 12, 2017 Filed Nov 1, 2017 23:29 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | GiftCommon Stock | 53 | $0.00 | $0.00 |
DisclosureSEC source: 0001234778-17-000007 · primary_doc.xml · nonDerivative · entry 5 LARKIN C RAYMOND JR · CIK 0001034464 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,201 Read SEC document |
| September 25, 2017 Filed Nov 1, 2017 23:29 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | GiftCommon Stock | 27 | $0.00 | $0.00 |
DisclosureSEC source: 0001234778-17-000007 · primary_doc.xml · nonDerivative · entry 4 LARKIN C RAYMOND JR · CIK 0001034464 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,281 Read SEC document |
| September 20, 2017 Filed Nov 1, 2017 23:29 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | GiftCommon Stock | 27 | $0.00 | $0.00 |
DisclosureSEC source: 0001234778-17-000007 · primary_doc.xml · nonDerivative · entry 3 LARKIN C RAYMOND JR · CIK 0001034464 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,281 Read SEC document |
| July 06, 2017 Filed Nov 1, 2017 23:29 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | GiftCommon Stock | 40 | $0.00 | $0.00 |
DisclosureSEC source: 0001234778-17-000007 · primary_doc.xml · nonDerivative · entry 2 LARKIN C RAYMOND JR · CIK 0001034464 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,308 Read SEC document |
| May 17, 2017 Filed May 18, 2017 23:05 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | GrantRestricted Stock Unit · Derivative | 4,344 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001288257-17-000007 · primary_doc.xml · derivative · entry 4 LARKIN C RAYMOND JR · CIK 0001034464 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,344 Underlying: Common Stock · 4,344 shares Expires not disclosed F1 · derivative.exercise_price: Represents par value of ALGN common stock F3 · derivative.exercise_date: 100% of the restricted stock unit will become vested upon the earlier of (I) one year after the date of grant or (ii) the date of issuer's annual meeting of stockholders to be held in 2018. Shares will be delivered to reporting person on the vest date. F3 · derivative.expiration_date: 100% of the restricted stock unit will become vested upon the earlier of (I) one year after the date of grant or (ii) the date of issuer's annual meeting of stockholders to be held in 2018. Shares will be delivered to reporting person on the vest date. Read SEC document |
| May 17, 2017 Filed May 18, 2017 23:05 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | Exercise / conversionRestricted Stock Unit · Derivative | 7,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001288257-17-000007 · primary_doc.xml · derivative · entry 3 LARKIN C RAYMOND JR · CIK 0001034464 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Represents par value of ALGN common stock F2 · derivative.exercise_date: 100% of the restricted stock unit granted on May 18, 2016 became vested on May 17, 2017 and shares were delivered to reporting person on May 17, 2017. F2 · derivative.expiration_date: 100% of the restricted stock unit granted on May 18, 2016 became vested on May 17, 2017 and shares were delivered to reporting person on May 17, 2017. Read SEC document |
| May 17, 2017 Filed May 18, 2017 23:05 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | Exercise / conversionCommon Stock | 7,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001288257-17-000007 · primary_doc.xml · nonDerivative · entry 2 LARKIN C RAYMOND JR · CIK 0001034464 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,562 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 17, 2017 Filed Nov 1, 2017 23:29 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | GiftCommon Stock | 214 | $0.00 | $0.00 |
DisclosureSEC source: 0001234778-17-000007 · primary_doc.xml · nonDerivative · entry 1 LARKIN C RAYMOND JR · CIK 0001034464 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,348 Read SEC document |
| March 31, 2017 Filed May 18, 2017 23:05 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | GiftCommon Stock | 289 | $0.00 | $0.00 |
DisclosureSEC source: 0001288257-17-000007 · primary_doc.xml · nonDerivative · entry 1 LARKIN C RAYMOND JR · CIK 0001034464 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,562 Read SEC document |
| February 03, 2017 Filed Feb 6, 2017 21:59 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | Exercise / conversionRight to Buy (Common Stock) · Derivative | 15,000 | $0.00 Strike: $17.94 | $0.00 |
DisclosureSEC source: 0001234778-17-000001 · primary_doc.xml · derivative · entry 4 LARKIN C RAYMOND JR · CIK 0001034464 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires 2017-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 03, 2017 Filed Feb 6, 2017 21:59 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | SaleCommon Stock | 15,000 | $94.71 | $1,420,663.50 |
DisclosureSEC source: 0001234778-17-000001 · primary_doc.xml · nonDerivative · entry 2 LARKIN C RAYMOND JR · CIK 0001034464 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,012 F1 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.14 to $95.89, inclusive. The reporting person undertakes to provide Align Technology, Inc., any security holder of Align Technology, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 03, 2017 Filed Feb 6, 2017 21:59 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | Exercise / conversionCommon Stock | 15,000 | $17.94 | $269,100.00 |
DisclosureSEC source: 0001234778-17-000001 · primary_doc.xml · nonDerivative · entry 1 LARKIN C RAYMOND JR · CIK 0001034464 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,012 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 25, 2017 Filed Feb 6, 2017 21:59 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | GiftCommon Stock | 161 | $0.00 | $0.00 |
DisclosureSEC source: 0001234778-17-000001 · primary_doc.xml · nonDerivative · entry 3 LARKIN C RAYMOND JR · CIK 0001034464 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,851 Read SEC document |
| December 21, 2016 Filed Jan 4, 2017 22:16 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | GiftCommon Stock | 200 | $0.00 | $0.00 |
DisclosureSEC source: 0001233163-17-000002 · primary_doc.xml · nonDerivative · entry 3 LARKIN C RAYMOND JR · CIK 0001034464 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,012 Read SEC document |
| September 19, 2016 Filed Jan 4, 2017 22:16 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | GiftCommon Stock | 125 | $0.00 | $0.00 |
DisclosureSEC source: 0001233163-17-000002 · primary_doc.xml · nonDerivative · entry 2 LARKIN C RAYMOND JR · CIK 0001034464 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,212 Read SEC document |
| May 31, 2016 Filed Jan 4, 2017 22:16 UTC | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | GiftCommon Stock | 400 | $0.00 | $0.00 |
DisclosureSEC source: 0001233163-17-000002 · primary_doc.xml · nonDerivative · entry 1 LARKIN C RAYMOND JR · CIK 0001034464 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,337 Read SEC document |
| June 23, 2015 Filed Feb 16, 2019 00:38 UTC Amendment | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | GiftCommon Stock | 125 | $0.00 | $0.00 |
DisclosureSEC source: 0001288257-19-000003 · primary_doc.xml · nonDerivative · entry 4 LARKIN C RAYMOND JR · CIK 0001034464 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,046 Read SEC document |
| June 22, 2015 Filed Feb 16, 2019 00:38 UTC Amendment | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | GiftCommon Stock | 140 | $0.00 | $0.00 |
DisclosureSEC source: 0001288257-19-000003 · primary_doc.xml · nonDerivative · entry 3 LARKIN C RAYMOND JR · CIK 0001034464 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,171 Read SEC document |
| March 27, 2015 Filed Feb 16, 2019 00:38 UTC Amendment | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | GiftCommon Stock | 250 | $0.00 | $0.00 |
DisclosureSEC source: 0001288257-19-000003 · primary_doc.xml · nonDerivative · entry 2 LARKIN C RAYMOND JR · CIK 0001034464 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,311 Read SEC document |
| May 24, 2013 Filed Feb 16, 2019 00:38 UTC Amendment | ALIGN TECHNOLOGY INC ALGN · Entity 3488 | GiftCommon Stock | 266 | $0.00 | $0.00 |
DisclosureSEC source: 0001288257-19-000003 · primary_doc.xml · nonDerivative · entry 1 LARKIN C RAYMOND JR · CIK 0001034464 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,561 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.